Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting ...
T Cha is no ordinary young, Sun-like star. It is surrounded by a circumstellar disk, the dense, rotating structure of gas and ...
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small ...
Japan's Cabinet has approved a record defense budget plan exceeding 9 trillion yen ($58 billion) to acquire stronger ...
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and ...
Mumbai (Maharashtra) [India], December 24: Actor, Entrepreneur, and style icon Shilpa Shetty announces her much awaited signature Mangalsutra Bracelet collection, this time crafted in purest Type IIa ...
As the first domestic anti-ST2 monoclonal antibody candidate to enter clinical trials, 9MW1911 binds to the ST2 receptor with high affinity to block the IL-33/ST2 signaling pathway. It has already ...
TipRanks on MSN
Clearmind Medicine highlights key 2025 achievements
The company said, “Throughout 2025, Clearmind achieved critical milestones in its FDA-approved Phase I/IIa clinical trial for CMND-100, a ...
Vancouver, Canada, Dec. 24, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of ...
Jupiter, Florida, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL ™, a patented ...
No one's crossed the finishing line yet, but drug developer Nyrada is leading the Great Biotech Regatta of 2025 with close to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback